Factors associated with parents' willingness to enroll their children in trials for COVID-19 vaccination.

Published on Jun 3, 2021in Human Vaccines & Immunotherapeutics2.619
· DOI :10.1080/21645515.2020.1834325
Ran D. Goldman33
Estimated H-index: 33
(UBC: University of British Columbia),
Georg Staubli11
Estimated H-index: 11
(Boston Children's Hospital)
+ 16 AuthorsEileen J. Klein29
Estimated H-index: 29
(UW: University of Washington)
Sources
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has taken an unprecedented global toll and vaccination is needed to restore healthy living. Timely inclusion of children in vaccination trials is critical. We surveyed caregivers of children seeking care in 17 Emergency Departments (ED) across 6 countries during the peak of the pandemic to identify factors associated with intent to participate in COVID-19 vaccine trials. Questions about child and parent characteristics, COVID-19 expressed concerns and parental attitudes toward participation in a trial were asked. Of 2768 completed surveys, 18.4% parents stated they would enroll their child in a clinical trial for a COVID-19 vaccine and 14.4% would agree to a randomized placebo-controlled study. Factors associated with willingness to participate were parents agreeing to enroll in a COVID-19 vaccine trial themselves (Odds Ratio (OR) 32.9, 95% Confidence Interval (CI) (21.9-51.2)) having an older child (OR 1.0 (1.0-1.01)), having children who received all vaccinations based on their country schedule (OR 2.67 (1.35-5.71)) and parents with high school education or lower (OR 1.79 (1.18-2.74)). Mothers were less likely to enroll their child in a trial (OR 0.68 (0.47-0.97)). Only one fifth of families surveyed will consider enrolling their child in a vaccine trial. Parental interest in participation, history of vaccinating their child, and the child being older all are associated with parents allowing their child to participate in a COVID vaccine trial. This information may help decision-makers and researchers shape their strategies for trial design and participation engagement in upcoming COVID19 vaccination trials.
Download
References21
Newest
#1Linda Thunström (UW: University of Wyoming)H-Index: 14
#2Madison Ashworth (UW: University of Wyoming)H-Index: 5
Last. Stephen C. Newbold (UW: University of Wyoming)H-Index: 15
view all 4 authors...
The scientific community has come together in an unprecedented effort to find a COVID-19 vaccine. However, its success in the U.S. depends on the share of the population that gets vaccinated. We design a randomized controlled trial (RCT) survey in which a nationally representative sample of 3,133 participants state their intentions to vaccinate themselves and their children for COVID-19. We account for uncertainty about the severity and infectiousness of COVID-19 and potential inconsistencies in...
43 CitationsSource
#1Sing Yu Moorcraft (The Royal Marsden NHS Foundation Trust)H-Index: 11
#2C. Marriott (The Royal Marsden NHS Foundation Trust)H-Index: 3
Last. Sheela Rao (The Royal Marsden NHS Foundation Trust)H-Index: 25
view all 8 authors...
Background Recruitment to clinical trials can be challenging and slower than anticipated. This prospective patient survey aimed to investigate the proportion of patients approached about a trial who agree to participate, their motivations for trial participation and their views on aspects of cancer research.
89 CitationsSource
#1Alejandro HobermanH-Index: 48
#2Nader ShaikhH-Index: 27
Last. Russell W. ChesneyH-Index: 59
view all 16 authors...
child’s participation in the randomized trial were invitedtocompleteananonymousonlinesurveyaboutfactors influencing their decision. A total of 120 of the 271 (44%)invitedcompletedthesurvey;58of125(46%)who had provided consent and 62 of 144 (43%) who had declined consent completed the survey. Main Outcomes and Measures: A 60-question surveyexaminingchild,parent,andstudycharacteristics;pa
6 Citations
#1Annette Rid ('KCL': King's College London)H-Index: 23
#2Abha Saxena (WHO: World Health Organization)H-Index: 11
Last. P. Smith (Lond: University of London)H-Index: 1
view all 22 authors...
Vaccines are among the most cost-effective interventions against infectious diseases. Many candidate vaccines targeting neglected diseases in low- and middle-income countries are now progressing to large-scale clinical testing. However, controversy surrounds the appropriate design of vaccine trials and, in particular, the use of unvaccinated controls (with or without placebo) when an efficacious vaccine already exists. This paper specifies four situations in which placebo use may be acceptable, ...
29 CitationsSource
#1Domino Determann (EUR: Erasmus University Rotterdam)H-Index: 8
#2Ida J. Korfage (EUR: Erasmus University Rotterdam)H-Index: 36
Last. Esther W. de Bekker-Grob (EUR: Erasmus University Rotterdam)H-Index: 24
view all 7 authors...
textabstractBackground: Preventive measures are essential to limit the spread of new viruses; their uptake is key to their success. However, the vaccination uptake in pandemic outbreaks is often low. We aim to elicit how disease and vaccination characteristics determine preferences of the general public for new pandemic vaccinations. Methods: In an internet-based discrete choice experiment (DCE) a representative sample of 536 participants (49% participation rate) from the Dutch population was as...
54 CitationsSource
#1Alejandro Hoberman (University of Pittsburgh)H-Index: 48
#2Nader Shaikh (University of Pittsburgh)H-Index: 27
Last. Russell W. ChesneyH-Index: 59
view all 16 authors...
Importance A child's health, positive perceptions of the research team and consent process, and altruistic motives play significant roles in the decision-making process for parents who consent for their child to enroll in clinical research. This study identified that nonconsenting parents were better educated, had private insurance, showed lower levels of altruism, and less understanding of study design. Objective To determine the factors associated with parental consent for their child's partic...
73 CitationsSource
#1Helen R. FisherH-Index: 11
Last. Annette BoazH-Index: 26
view all 3 authors...
Objective Recent legislation mandating the inclusion of children in clinical trials has resulted in an increase in the number of children participating in research. We reviewed the literature regarding the reasons parents chose to accept or decline an invitation to enrol their children in clinical research. Methods We searched for qualitative studies, written in the English language that considered the experiences of parents who had been invited to enrol their children in research. SCOPUS and We...
36 CitationsSource
#1Patrina H Y Caldwell (USYD: University of Sydney)H-Index: 23
#2Sana Hamilton (Children's Hospital at Westmead)H-Index: 3
Last. Jonathan C. Craig (USYD: University of Sydney)H-Index: 124
view all 4 authors...
Background Recruitment of participants into randomised controlled trials (RCTs) is critical for successful trial conduct. Although there have been two previous systematic reviews on related topics, the results (which identified specific interventions) were inconclusive and not generalizable. The aim of our study was to evaluate the relative effectiveness of recruitment strategies for participation in RCTs.
186 CitationsSource
#1Maria E Perez (Atlantic Health System)H-Index: 1
#2Annette LangsederH-Index: 8
Last. Nader N. YoussefH-Index: 14
view all 4 authors...
Background and Objectives: Investigators may have concerns that parents will not allow their children to participate in placebo-controlled trials (PCTs). The aim of the present study was to identify potential differences between parental perceptions in families who successfully completed (CO) a clinical trial compared with those who were noncompleters (NC). Patients and Methods: Parents of both CO and NC children enrolled in pediatric gastrointestinal studies performed in the previous year were ...
5 CitationsSource
: Childhood cancer requires families to deal with many stressors, including decision making in terms of their child's treatment. Adding to the stress of families is that most children participate in clinical research trials. Minimal research has been done to explore parents' decisions related to involving their child in childhood cancer clinical trials. Especially missing is a description of Canadian parents' perspectives. This article describes a qualitative study that sought to understand Cana...
37 CitationsSource
Cited By6
Newest
#1Zixin Wang (CUHK: The Chinese University of Hong Kong)H-Index: 14
#2Rui She (CUHK: The Chinese University of Hong Kong)H-Index: 5
Last. Joseph Lau (CUHK: The Chinese University of Hong Kong)H-Index: 159
view all 7 authors...
This study investigated parental acceptability of COVID-19 vaccination for children under the age of 18 years among Chinese parents who are healthcare workers. A closed online survey among full-time doctors or nurses employed by the five collaborative hospitals who had access to smartphones was conducted. Facilitated by the hospital administrators, prospective participants received an invitation sent by the research team via the existing WeChat/QQ groups to complete an online questionnaire. A to...
Source
Source
Introduction This study aimed to evaluate the parental willingness and attitudes concerning the COVID-19 vaccine. Method This cross-sectional study was performed using a self-administered online survey, covering parents' and their children's characteristics, parental willingness, and attitudes towards the COVID-19 vaccine. A total of 1035 parents participated. Results Analysis showed that 36.3% of parents were willing to have their children receive the COVID-19 vaccine and that 59.9% were willin...
2 CitationsSource
#1Olivier DrouinH-Index: 7
Last. Silva Rbd
view all 6 authors...
Source
#1Elizabeth B PathakH-Index: 12
#2Janelle MenardH-Index: 1
view all 3 authors...
Background: We examined the geographic and racial/ethnic distribution of the SARS-CoV-2 vaccine age-ineligible population (0-15 years old) in the U.S., and calculated the proportion of the age-eligible population that will need to be vaccinated in a given geo-demographic group in order to achieve either 60% or 75% vaccine coverage for that population as a whole. Methods: US Census Bureau population estimates for 2019 were used to calculate the percent vaccine ineligible and related measures for ...
Source
Source